MENU
ITRM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Iterum Therapeutics (ITRM) Ownership - Who owns Iterum Therapeutics?

Industry: @Biotechnology

Profile

Industry
Biotechnology
Address
Fitzwilliam Court
Phone
+353 16694820
Employees
14
Web
https://www.iterumtx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
50.35M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
20.18M
Revenue
N/A
Risk (Beta)
3.48
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

ITRM
Capitalization
50.4M
P/E Ratio
N/A
Risk (Beta)
3.48
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
20.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
-6.15M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
165K
Current Ratio
1.07
Current Revenue Per Employee
770.83
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
75.7M
Shares Outstanding - Current
27.5M
Total Liabilities
25.8M
Total Volume MTD
N/A
Value
-1
Gain YTD
-7.107
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an operator, which engages in the healthcare industry focusing on biotechnology business

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Fitzwilliam Court
Phone
+353 16694820
Employees
14
Web
https://www.iterumtx.com